abc7news.comNot Dead Yet: The Fight over 'Death' in Organ TransplantationNational Review Online“Brain death” is exceedingly controversial, but logistically presents a luxury of time to wrangle over ethics and still comply with a person'…
StemCells, Inc. Announces World's First Neural Stem Cell Transplant in Spinal …MarketWatch (press release)NEWARK, Calif., Sep 22, 2011 (GlobeNewswire via COMTEX) — StemCells, Inc. announced today that the first patient in the Company's break…
Kidney Transplantation Ends With Donor And Receiver Suing HospitalThirdAgeBoth donor and recipient of a kidney transplantation have filed medical malpractice lawsuits against the University of Pittsburgh Medical Center, officials say. Michael Yocabet, …
First Things (blog)Don't Rush to Harvest OrgansFirst Things (blog)I have written in support of the non heart beating cadaver donor method for procuring organs–sometimes called heart death to differentiate it from the “brain death” (really, de…
Cold Ischemia Time Tied to Delayed Kidney Graft FunctionMD News (press release)Increasing cold ischemia time in expanded-criteria donor kidney pairs is a risk factor for delayed graft function, but has no effect on graft survival, according to a study …
Times LIVEStem cell transplant program helps patients fight diseaseBillings GazetteSue DeLaMater said a stem cell transplant has not only prolonged her life but saved it. Sue DeLaMater had undergone myriad radiation and chemotherapy treatments to er…
A different definition of deathWashington PostThe percentage of organs being obtained for transplants through “donation after cardiac death” instead of “brain death” is small but rising. Read related article. Source: United Network for Organ Sh…
ThirdAgeHeart failure hits the poor extra hardReutersNEW YORK (Reuters Health) – Poor women are more likely to end up in the hospital with heart failure, even when taking other measures of health and well-being into consideration. That's according …
Liver Transplantation With Donation After Cardiac Death: A Treacherous Field …Archives of SurgeryStudies from large databases may identify factors, other than the ones included in this study, that may lead to improved outcomes in DCD liver transplant…
The Daily DealAbbott's emerging entranceThe Daily DealFacet had partnered with Biogen Idec Inc. on a multiple sclerosis drug, known as daclizumab, a monoclonal antibody being considered for uses ranging from the prevention of organ rejection in tra…